Aspira Women's Health's (AWH) CEO Valerie Palmieri on Q2 2021 Results - Earnings Call Transcript

Aspira Women's Health Inc. (AWH) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET

Company Participants

Valerie Palmieri – President and Chief Executive Officer
Kaile Zagger – Chief Operating Officer
Rob Beechey – Chief Financial Officer
Elena Ratner – Global Chief Medical Advisor, Clinical and Translational Medicine
Lesley Northrop – Chief Scientific Officer

Conference Call Participants

Brian Weinstein – William Blair
Charles Duncan – Cantor

Operator

Good afternoon ladies and gentlemen. And welcome Aspira Women's Health’s Second Quarter 2021 Conference Call. My name is Shimoli and I will be your coordinator for the call today. At this time all participants are in a listen-only mode. Following management’s prepared remarks we will open the call for your questions. As a reminder, this conference call is being recorded today.

Leading the call today are Valerie Palmieri, President and Chief Executive Officer; Rob Beechey, Chief Financial Officer; and Kaile Zagger, Chief Operating Officer; and Dr. Lesley Northrop, Chief Scientific Officer; and Dr. Elena Ratner, Global Chief Medical Advisor, Clinical and Translational Medicine.

After the prepared remarks, we'll open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A Session relating to Aspira’s expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those anticipated due to the impact of many factors beyond the control of Aspira. The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law. Participants are directed to the cautionary note